(19)
(11) EP 4 313 101 A1

(12)

(43) Date of publication:
07.02.2024 Bulletin 2024/06

(21) Application number: 22782030.5

(22) Date of filing: 29.03.2022
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
A61K 38/08(2019.01)
A61K 38/10(2006.01)
A61K 38/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/00; C07K 14/4736; A61P 35/00; A61K 45/06
(86) International application number:
PCT/US2022/022363
(87) International publication number:
WO 2022/212389 (06.10.2022 Gazette 2022/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 29.03.2021 US 202117215845

(71) Applicant: Saint Leo University
Saint Leo FL 33574-6665 (US)

(72) Inventor:
  • BORYSOV, Sergiy
    Tampa, FL 33618 (US)

(74) Representative: Botti & Ferrari S.p.A. 
Via Cappellini, 11
20124 Milano
20124 Milano (IT)

   


(54) PEPTIDE FOR TREATING CANCER